Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19

Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19

Saved in:

Bibliographic Details
Main Authors:	Queen Revollido, Lydia Buzzard, David X. Lee, Matthew Strnad, Scott McLoud, Akram Khan, William B. Messer, David H. Farrell
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Blood Vessels, Thrombosis & Hemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950327225000051
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Albumin-To-Fibrinogen and Fibrinogen-To-Prealbumin Ratios in the Development of Ovarian Carcinoma
by: Racheva V., et al.
Published: (2025-03-01)

Fibrinogen/albumin ratio is associated with first-ever cardiovascular events in patients with peritoneal dialysis
by: Qiqi Yan, et al.
Published: (2025-12-01)

Serum fibrinogen level and fibrinogen administration in patients with traumatic brain injury: A systematic review and meta-analysis protocol
by: Joanne Igoli, et al.
Published: (2025-01-01)

Serum fibrinogen level and fibrinogen administration in patients with traumatic brain injury: A systematic review and meta-analysis protocol.
by: Joanne Igoli, et al.
Published: (2025-01-01)

Common FXIII and fibrinogen polymorphisms in abdominal aortic aneurysms.
by: Fraser L Macrae, et al.
Published: (2014-01-01)

Fibrinogen and Neuroinflammation in the Neurovascular Unit in Stroke
by: Chen Y, et al.
Published: (2025-04-01)

Fibrinogen-to-Albumin Ratio as a Novel Predictor of Intracerebral Hemorrhage in Maintenance Hemodialysis Patients
by: He X, et al.
Published: (2025-06-01)

Serum fibrinogen is not elevated in patients with myasthenia gravis
by: Taylor A. Bauman, et al.
Published: (2025-04-01)

Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function
by: Francesca Nencini, et al.
Published: (2025-03-01)

Clinical Significance and Correlation of Plasma D-Dimer, Fibrinogen, and Cytokines in Idiopathic Inflammatory Myopathy
by: Jiang X, et al.
Published: (2025-07-01)

Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
by: Matthew Warren Brunke, et al.
Published: (2025-07-01)

Microbiota γ‐Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy
by: Zheng‐Wei Chen, et al.
Published: (2025-08-01)

Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
by: Mike Farrell, et al.
Published: (2025-05-01)

Association of preoperative to postoperative change in cerebrospinal fluid fibrinogen with postoperative delirium
by: Thomas Payne, et al.
Published: (2024-12-01)

Minor Adverse Events Postcolonoscopy
by: Catherine Dubé
Published: (2014-01-01)

Safety of creatine supplementation: Analysis of Adverse Events reported in clinical trials and adverse event reports
by: Sarah E. Johnson, et al.
Published: (2025-09-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2025-05-01)

Encapsulation of fibrinogen and thrombin with calcium carbonate for hemorrhage control
by: Henry T Peng, et al.
Published: (2023-07-01)

A call to action for adverse drug event (ADE) detection and prevention
by: John McCue, et al.
Published: (2025-03-01)

Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-05-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Systematic Review: Adverse Events of Fecal Microbiota Transplantation.
by: Sinan Wang, et al.
Published: (2016-01-01)

Association of adverse cardiovascular events with gabapentin and pregabalin among patients with fibromyalgia.
by: Yiheng Pan, et al.
Published: (2024-01-01)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01)

Fibrinogen/Albumin Ratio is Associated with the Occurrence of Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure
by: Zhang G, et al.
Published: (2025-04-01)

Factors influencing adverse events following COVID-19 vaccination
by: Paola Villanueva, et al.
Published: (2024-12-01)

What to do in the event of an adverse anaesthetic event or medical error
by: Jenny Thomas
Published: (2014-05-01)

Exploring Novel Adverse Events of Nefecon
by: Jingyu Wang, et al.
Published: (2024-09-01)

Neurologic adverse events of cancer immunotherapy
by: Marcelo Houat de Brito
Published: (2022-08-01)

An infrequent but unpleasant adverse event of Tamsulosin
by: Antonio Villa
Published: (2024-04-01)

Emulsion-Based Encapsulation of Fibrinogen with Calcium Carbonate for Hemorrhage Control
by: Henry T. Peng, et al.
Published: (2025-03-01)

Soluble fibrinogen-like protein 2 in condyloma acuminatum lesions
by: Mei Zeng, et al.
Published: (2020-06-01)

Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis
by: Eleonora Fini, et al.
Published: (2024-11-01)

Platelet and Fibrinogen Contribution to Clot Strength in Premature Neonates with Sepsis
by: Dimitra Gialamprinou, et al.
Published: (2025-07-01)

Gardnerella fibrinogen-binding protein as a candidate adherence factor
by: Aistė Bulavaitė, et al.
Published: (2025-05-01)

Fibrinogen kao faktor rizika za ishemijsku bolest srca
by: Obradović Slobodan, et al.
Published: (2003-01-01)

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-06-01)